Approval · Notice of Compliance 36050 · 2025
PROVOCHOLINE: Notice of Compliance 36050
Issued September 23, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36050
- Date
- September 23, 2025
- Company
- Methapharm Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROVOCHOLINE | Not yet assigned | — |
Medicinal ingredients
- METHACHOLINE CHLORIDE 160 MG per VIAL
- METHACHOLINE CHLORIDE 1,280 MG per VIAL
- METHACHOLINE CHLORIDE 320 MG per VIAL
- METHACHOLINE CHLORIDE 1,600 MG per VIAL
- METHACHOLINE CHLORIDE 100 MG per VIAL